Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia

SIMPLE SUMMARY: Patients with high-risk acute leukemia (AL) have a high risk of relapse after allogeneic stem cell transplantation (allo-SCT). Prophylactic donor lymphocyte infusion (pro-DLI) has shown significant efficacy in reducing relapse rate but its widespread application has been limited due...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsirigotis, Panagiotis, Gkirkas, Konstantinos, Kitsiou, Vassiliki, Chondropoulos, Spiros, Athanassiades, Theofilos, Thomopoulos, Thomas, Tsirogianni, Alexandra, Stamouli, Maria, Karagiannidi, Aggeliki, Siafakas, Nikolaos, Pappa, Vassiliki, Nagler, Arnon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198731/
https://www.ncbi.nlm.nih.gov/pubmed/34070786
http://dx.doi.org/10.3390/cancers13112699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198731/
https://www.ncbi.nlm.nih.gov/pubmed/34070786
http://dx.doi.org/10.3390/cancers13112699

Ejemplares similares